Stockscreener 앱 받기
118.21
0.44%
-0.52
시간 외 거래:
118.21
전일 마감가:
$118.73
열려 있는:
$119.5
하루 거래량:
583.88K
Relative Volume:
0.64
시가총액:
$5.38B
수익:
$1.33B
순이익/손실:
$97.31M
주가수익비율:
58.18
EPS:
2.0317
순현금흐름:
$260.44M
1주 성능:
-2.88%
1개월 성능:
+9.05%
6개월 성능:
+93.25%
1년 성능:
+133.11%
1일 변동 폭
$117.20
$120.50
1주일 범위
$117.00
$122.53
52주 변동 폭
$48.98
$123.77
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
Compare HAE vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
118.21 | 5.38B | 1.33B | 97.31M | 260.44M | 2.0317 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-05-22 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-05-12 | 재확인 | Barrington Research | Outperform |
| 2025-12-15 | 다운그레이드 | Needham | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
Haemonetics: CSL Plasma Improves The Outlook, Not The Entry Point (Rating Downgrade) - Seeking Alpha
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo! Finance Canada
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength? - Zacks Investment Research
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength? - Yahoo Finance
Haemonetics (HAE) Jumped, What Is Behind The Move? - Yahoo Finance
Haemonetics (HAE) Surges Over 17% on Plasma Supply Deal with CSL - GuruFocus
Haemonetics Corporation Stock 12‑Month Price Target Raised to $120, Implies 18% Upside - TradingView
Haemonetics advances 17% on CSL supply deal (HAE:NYSE) - Seeking Alpha
Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - Timothy Sykes
Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - StocksToTrade
Haemonetics (HAE) Shares Skyrocket, What You Need To Know - Yahoo Finance
Haemonetics (HAE) Surges 12.8% to $114.69 - AlphaStreet
Haemonetics Stock Climbs As Citi Hikes Price Target On CSL Upside - StocksToTrade
Haemonetics (HAE) Stock Climbs After Citi Ups Price Target - www.timothysykes.com
Haemonetics (HAE) Stock Climbs After Citi Ups Price Target - Timothy Sykes
Haemonetics Jumps to 52-Week High as CSL Plasma Plans Full U.S. Device Rollout by 2027 - finance.biggo.com
Haemonetics jumps after strong Q4 results and fiscal 2027 outlook - Quiver Quantitative
Haemonetics Stock Hits 52-Week HighHere's Why - Benzinga
Haemonetics Stock Hits 52-Week HighHere's Why - Benzinga
Haemonetics Stock Hits 52-Week HighHere's Why - TradingView
Haemonetics Says CSL Plasma to Complete Rollout of Products by End-2027 - marketscreener.com
Haemonetics Stock Pops As Citi Hikes Price Target To $123 - StocksToTrade
Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - Timothy Sykes
Why is Haemonetics stock surging today? - Investing.com
Haemonetics shares jump as CSL sets 2027 rollout of plasma devices - Yahoo Finance
Haemonetics (HAE) Surges 12.8% to $114.69 - AlphaStreet
Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers - Yahoo Finance
Haemonetics stock hits 52-week high at 114.0 USD - Investing.com
BTIG raises Haemonetics stock price target on CSL Plasma deal - Investing.com
Why is Haemonetics stock surging today? - Investing.com
Haemonetics stock surges 17% on CSL Plasma supply deal update - Yahoo Finance
Haemonetics Shares Gain as CSL Targets Rollout of Company's Devices by End of 2027 - marketscreener.com
Haemonetics (HAE) Secures Supply Deal with CSL Plasma for NexSys PCS Devices - GuruFocus
Haemonetics stock surges 17% on CSL Plasma supply deal update - Investing.com
Haemonetics gains after update on CSL supply deal (HAE:NYSE) - Seeking Alpha
Haemonetics: Non‑exclusive CSL Plasma supply deal; rollout expected by end‑2027 - TradingView
A rollout to all current U.S. CSL plasma centers is anticipated for Haemonetics (HAE), subject to change. - Stock Titan
CSL Expands Relationship With Haemonetics Corporation - TradingView
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
Haemonetics Q1 2027 Earnings Call Transcript - Benzinga
BTIG reiterates Buy rating on Haemonetics with $84 target - scanx.trade
Haemonetics stock heads into November 5 results with key benchmarks - AD HOC NEWS
Haemonetics stock heads into November 5 results after earnings beat - AD HOC NEWS
Haemonetics Corporation (NYSE: HAE) Share Price, HAE Stock News, HAE Share Price & Updates - kalkine.ca
Haemonetics Corporation (HAE) Stock forecasts - Yahoo Finance Singapore
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo! Finance Canada
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
Haemonetics sets Q2FY27 earnings release date for November 5 - scanx.trade
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.01%
0.04%
자본화:
|
볼륨(24시간):